Skip to main content

by Dr. C.H. Weaver 11/2022
  • As the month of November brings lung cancer into focus it's important to note the great strides that have been made in the management of non small cell lung cancer (NSCLC) largely due to the advancement of precision cancer medicines and immunotherapy.

    Lung CancerConnect 490

    Lung cancer remains the second most common cancer in women (behind breast cancer) and also the second most common in men (behind prostate cancer). In 2022, there will be over 225,000 individuals diagnosed with lung cancer in the United States.

    Staying informed with the latest news on prevention, screening of high risk individuals, and treatment advances are all important in order to reducing the risk of developing lung cancer, ensure optimal care and achieve the best possible outcomes.

    Scroll to Continue

    Recommended Articles

    Lung Newsletter 490

    Information and Education

    Reference:

    American Cancer Society. Cancer Facts and Figures 2021. Available here.